These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA. Neacsu V; Jasperse B; Korteweg T; Knol DL; Valsasina P; Filippi M; Barkhof F; Rovaris M; Vrenken H; J Magn Reson Imaging; 2008 Sep; 28(3):559-65. PubMed ID: 18777529 [TBL] [Abstract][Full Text] [Related]
10. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017 [TBL] [Abstract][Full Text] [Related]
11. Measurement of brain atrophy in subcortical vascular disease: a comparison of different approaches and the impact of ischaemic lesions. O'Sullivan M; Jouvent E; Saemann PG; Mangin JF; Viswanathan A; Gschwendtner A; Bracoud L; Pachai C; Chabriat H; Dichgans M Neuroimage; 2008 Nov; 43(2):312-20. PubMed ID: 18722537 [TBL] [Abstract][Full Text] [Related]
12. Multiprotocol MR image segmentation in multiple sclerosis: experience with over 1,000 studies. Udupa JK; Nyúl LG; Ge Y; Grossman RI Acad Radiol; 2001 Nov; 8(11):1116-26. PubMed ID: 11721811 [TBL] [Abstract][Full Text] [Related]
13. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. Frohman EM; Dwyer MG; Frohman T; Cox JL; Salter A; Greenberg BM; Hussein S; Conger A; Calabresi P; Balcer LJ; Zivadinov R J Neurol Sci; 2009 Jul; 282(1-2):96-105. PubMed ID: 19439327 [TBL] [Abstract][Full Text] [Related]
14. Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E; Lee JC; Nakamura K; Rudick RA Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561 [TBL] [Abstract][Full Text] [Related]
15. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153 [TBL] [Abstract][Full Text] [Related]
16. Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements. Sampat MP; Healy BC; Meier DS; Dell'Oglio E; Liguori M; Guttmann CR Neuroimage; 2010 Oct; 52(4):1367-73. PubMed ID: 20362675 [TBL] [Abstract][Full Text] [Related]
17. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729 [TBL] [Abstract][Full Text] [Related]
18. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis. Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420 [TBL] [Abstract][Full Text] [Related]
19. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging. Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474 [TBL] [Abstract][Full Text] [Related]